Divergences in KIR2D+ natural killer and KIR2D+CD8+ T-cell reconstitution following liver transplantation

Human Immunology

Volumn 72, Issue 3, 2011, Pages 229-237

  Lopez Alvarez M R ^a,c   Campillo, J A ^a,c   Legaz, I ^a   Blanco Garcia R M ^a   Salgado Cecilia, G ^a   Bolarin J M ^a   Gimeno, L ^a   Gil, J ^b   Garcia Alonso A M ^a,c   Muro, M ^a,c   Alvarez Lopez M R ^a,c   Miras, M ^a,c   Minguela, A ^a,c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b Immunology Service   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

CD8 T lymphocytes; KIR2D receptors; Liver transplantation; NK cells; Tolerance

Indexed keywords

CD8 ANTIGEN; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1;

ACUTE GRAFT REJECTION; ADULT; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE EXPRESSION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; LIGAND BINDING; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER T CELL; PRIORITY JOURNAL; RECIPIENT; SIGNAL TRANSDUCTION;

CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HLA-C ANTIGENS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; RECEPTORS, KIR; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL3;

EID: 79651475047     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.12.015     Document Type: Article

References (48)

1. Benseler V., McCaughan G.W., Schlitt H.J., Bishop G.A., Bowen D.G., Bertolino P. The liver: a special case in transplantation tolerance. Semin Liver Dis 2007, 27:194-213.
2. Nikaein A., Backman L., Jennings L., Levy M.F., Goldstein R., Gonwa T., et al. HLA compatibility and liver transplant outcome Improved patient survival by HLA and cross-matching. Transplantation 1994, 58:786-792.
3. Ontañon J., Muro M., García-Alonso A.M., Minguela A., Torío A., Bermejo J., et al. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients. Transplantation 1998, 65:1047-1053.
4. Hanvesakul R., Spencer N., Cook M., Gunson B., Hathaway M., Brown R., et al. Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation. Am J Transplant 2008, 8:1931-1941.
5. López-Álvarez M.R., Moya-Quiles M.R., Minguela A., Gil J., Miras M., Campillo J.A., et al. HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+ KIR2D+ T-cells recuperation. Transplantation 2009, 88:S54-S61.
6. Tran T.H., Middleton D., Döhler B., Scherer S., Meenagh A., Sleator C., et al. Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival. Am J Transplant 2009, 9:1674-1678.
7. Fung J.J., Zeevi A., Starzl T.E., Demetris J., Iwatsuki S., Duquesnoy R.J. Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol 1986, 16:182-199.
8. Oërtel M., Kohlhaw K., Diepolder H.M., Schröder S., Schwarz R., Tannapfel A., et al. Alloreactivity of natural killer cells in allogeneic liver transplantation. Transplantation 2001, 72:116-122.
9. Bishara A., Brautbar C., Zamir G., Eid A., Safadi R. Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome. Hum Immunol 2005, 66:1099-1105.
10. de Arias A.E., Haworth S.E., Belli L.S., Burra P., Pinzello G., Vangeli M., et al. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. Liver Transplant 2009, 15:390-399.
11. Golden-Mason L. Natural killer cells play divergent roles in shaping the outcome of hepatitis C virus recurrence following liver transplantation. Liver Transplant 2009, 15:357-359.
12. Martínez-Llordella M., Lozano J.J., Puig-Pey I., Orlando G., Tisone G., Lerut J., et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008, 118:2845-2857.
13. Hsieh C.L., Obara H., Ogura Y., Martinez O.M., Krams S.M. NK cells and transplantation. Transpl Immunol 2002, 9:111-114.
14. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol 2001, 22:633-640.
15. Farag S.S., Caligiuri M.A. Human natural killer cell development and biology. Blood Rev 2006, 20:123-137.
16. Robertson M.J., Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990, 76:2421-2438.
17. Vilches C., Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002, 20:217-251.
18. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005, 5:201-214.
19. Parham P. Taking license with natural killer cell maturation and repertoire development. Immunol Rev 2006, 214:155-160.
20. Borrego F., Kabat J., Kim D.K., Lieto L., Maasho K., Peña J., et al. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol 2002, 38:637-660.
21. Lanier L.L. NK cell recognition. Annu Rev Immunol 2005, 23:225-274.
22. McQueen K.L., Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 2002, 14:615-621.
23. Remtoula N., Bensussan A., Marie-Cardine A. Cutting edge: selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytes. J Immunol 2008, 180:2767-2771.
24. Poggi A., Contini P., Catellani S., Setti M., Murdaca G., Zocchi R. Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 activating killer-Ig-like receptors. Eur J Immunol 2005, 35:267-268.
25. Colonna M., Borsellingo G., Falco M., Ferrara G.B., Strominger J.L. HLA-C is the inhibitory ligand that determined dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci U S A 1993, 90:12000-12004.
26. Mandelboim O., Reyburn H.T., Valés-Gómez M., Pazmany L., Colonna M., Borsellino G., et al. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med 1996, 184:913-922.
27. Anfossi N., André P., Guia S., Falk C.S., Roetynck S., Stewart C.A., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006, 25:331-342.
28. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005, 436:709-713.
29. Shilling H.G., McQueen K.L., Cheng N.W., Shizuru J.A., Negrin R.S., Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 2003, 101:3730-3740.
30. Fischer J.C., Ottinger H., Ferencik S., Sribar M., Punzel M., Beelen D.W., et al. Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor. J Immunol 2007, 178:3918-3923.
31. Giebel S., Dziaczkowska J., Czrew T., Wojnar J., Krawczyk-Kulis M., Nowak I., et al. Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT. Bone Marrow Transplant 2010, 10.1038/bmt.2009.384.
32. Uehara S., Chase C.M., Kitchens W.H., Rose H.S., Colvin R.B., Russell P.S., et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol 2005, 175:3424-3430.
33. McNerney M.E., Lee K.M., Zhou P., Molinero L., Mashayekhi M., Guzior D., et al. Role of natural killer cell subsets in cardiac allograft rejection. Am J Transplant 2006, 6:505-513.
34. Kang N., Guan D., Xing N., Xia C. Expression of CD158b on peripheral blood lymphocytic cell after kidney transplantation. Transplant Proc 2005, 37:782-784.
35. López-Álvarez M.R., Gómez-Mateo J., Ruíz-Merino G., Campillo J.A., Miras M., García-Alonso A.M., et al. Analysis of KIR2D receptors on peripheral blood lymphocytes from liver graft recipients. Transpl Immunol 2006, 17:51-54.
36. Mor E., Solomon H., Gibbs J.F., Colman M.J., Goldstein R.M., Husberg B.S., et al. Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome. Semin Liver Dis 1992, 12:28-40.
37. Campillo J.A., Martínez-Escribano J.A., Moya-Quiles M.R., Marín L.A., Muro M., Guerra N., et al. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients. Clin Cancer Res 2006, 12:4822-4831.
38. Speiser D.E., Valmori D., Rimoldi D., Pittet M.J., Liénard D., Cerundolo V., et al. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients. Eur J Immunol 1999, 29:1990-1999.
39. Moya-Quiles M.R., Álvarez R., Miras M., Gómez-Mateo J., Lopez-Álvarez M.R., Marín-Moreno I., et al. Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw*07 on acute rejection. Hum Immunol 2007, 68:51-58.
40. Becker S., Tom T., Füssel T., Uhrberg M., Bogdanow M., Seifried E., et al. Assessment of killer cell immunoglobulin-like receptor expression and corresponding HLA class I phenotypes demonstrates heterogeneous KIR expression independent of anticipated HLA class I ligands. Hum Immunol 2003, 64:183-193.
41. Ogura Y., Martinez O.M., Villanueva J.C., Tait J.F., Strauss H.W., Higgins J.P., et al. Apoptosis and allograft rejection in the absence of CD8+ T cells. Transplantation 2001, 71:1827-1834.
42. Yawata M., Yawata N., Draghi M., Little A.-M., Partheniou F., Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006, 203:633-645.
43. Cognet C., Farnarier C., Gauthier L., Frassati C., André P., Magérus-Chatinet A., et al. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells. Clin Immunol 2010, 135:26-32.
44. Zenhaeusern G., Gasser O., Hönger G., Durovic B., Stern M., Hess C. Regulatory allospecific NK cell function is differentially associated with HLA C allotypes. Am J Transplant 2009, 9:2624-2630.
45. Gerra N., Michel F., Gati A., Gaudin C., Mishal Z., Escudier B., et al. Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction. Blood 2002, 100:2874-2881.
46. Anfossi N., Doisne J.-M., Peyrat M.-A., Ugolini S., Bonnaud O., Bossy D., et al. Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells. J Immunol 2004, 173:7223-7229.
47. McMahon C.W., Zajac A.J., Jamieson A.M., Corral L., Hammer G.E., Ahmed R., et al. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells. J Immunol 2002, 169:1444-1452.
48. Shilling H.G., Young N., Guethlein L.A., Cheng N.W., Gardiner C.M., Tyan D., et al. Genetic control of human NK cell repertoire. J Immunol 2002, 169:239-247.